UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 66

of 'General principles of neoadjuvant therapy for breast cancer'

66
TI
Early survival analysis of the randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative and HER2-positive early breast cancer (GeparSixto).
AU
von Minckwitz G, Loibl S, Schneeweiss A, et al
SO
SABCS. 2015;abstract S2-04
 
AD